FindMyKOL

Antonio Calles

Enriched profile

Head of the Lung Cancer Unit, Hospital Ruber Internacional (Quirónsalud), Madrid · Hospital Ruber Internacional (Quirónsalud)

ORCID↗NPINone on file
✓ Itemized profile
Region🇪🇸 SpainSpecialtyMedical OncologyFocusLung Cancer Treatments and Mutations+4
Active KOLLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH fundingNone on fileWhy? →

Antonio Calles is Head of the Lung Cancer Unit, Hospital Ruber Internacional (Quirónsalud), Madrid at Hospital Ruber Internacional (Quirónsalud). OpenAlex indexes 211 publications with 4,535 citations (h-index 36); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 9 Nov 2026

Overview

Updated 11 Nov 2026

Antonio Calles is Head of the Lung Cancer Unit, Hospital Ruber Internacional (Quirónsalud), Madrid. The public record shows 211 publications with 4,535 citations (h-index 36), centered on Lung Cancer Treatments and Mutations, Lung Cancer Diagnosis and Treatment, Lung Cancer Research Studies. It also documents an investigator role on 5 registered clinical trials.

  • Most recent indexed publication: 2026 · Clinical cancer research
  • Top research focus: Lung Cancer Treatments and Mutations
  • 5 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 11 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Lung Cancer (NSCLC/SCLC)4 trialsSmall Cell Lung Carcinoma4 trialsMelanoma1 trialLymphoma1 trialBreast CancerColorectal CancerCOVID-19Gastroesophageal CancerNeuro-Oncology / GliomaPancreatic CancerSarcomaThyroid Disorders

Research focus

OpenAlex concept fingerprint
Lung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentLung Cancer Research StudiesCancer Genomics and DiagnosticsCancer Immunotherapy and Biomarkers

Drugs & molecules

across trials, industry payments and publications
AlectinibClinical trials1Industry payments—Publications—NeladalkibClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Antonio Calles BlancoClinical trials1Industry payments—Eli Lilly and CompanyClinical trials1Industry payments—Fundación GECPClinical trials1Industry payments—Nuvalent Inc.Clinical trials1Industry payments—Pierre Fabre MedicamentClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
211publications

Publications indexed by OpenAlex, matched via ORCID. 16 in PubMed. Counts exclude supporting files.

4,535citations

Citations across these publications.

36h-index

H-index from these publications. i10-index 70.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

0NIH grants

Federally funded research awards.

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

No public contact details on file. Research profiles have no U.S. clinical registration, so there's no federal registry record to draw an address or phone from. Why? →

Clinical trials

Updated 9 Nov 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Congress activity

Updated 9 Nov 2026

58 congress contributions (2011–2026) across AACR, AHA, ASCO, ESMO, IASLC, ISPOR Europe per OpenAlex. The most recent:

Publications

Updated 9 Nov 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Online presence

Updated 9 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • LinkedIn

    linkedin.com/in/antonio-calles-776b8145

    verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 9 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Associate Editor

    Frontiers (journal section not confirmed; listed as Associate Editor for Thoracic Oncology on Frontiers Oncology editors page)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →theorg.com ↗
  • Faculty member

    Lung and other Thoracic Tumours group, European Society for Medical Oncology (ESMO)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →quironsalud.com ↗

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.